1 year return (CAGR)
-4.12%
Innate Pharma Exchange (NASDAQ, USD)
IPHA
1.86
-0.04 (-2.11%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-15.36%
5 year return (CAGR)
-19.93%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
207.76M
Price/Sales
49.81
Ent value
264.07M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-8.21%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.86 |
| Daily high | 1.86 |
| Daily low | 1.80 |
| Daily Volume | 77K |
| All-time high | 8.20 |
| 1y analyst estimate | 6.67 |
| Beta | 0.86 |
| EPS (TTM) | -1.11 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 26 Mar 2026 |
Downside potential
Loading...
Downside potential data
| IPHA | S&P500 | |
| Current price drop from All-time high | -77.32% | -0.56% |
| Highest price drop | -85.73% | -56.47% |
| Date of highest drop | 20 Mar 2026 | 9 Mar 2009 |
| Avg drop from high | -58.59% | -10.68% |
| Avg time to new high | 109 days | 12 days |
| Max time to new high | 1599 days | 1805 days |
News
